[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"sensory-processing-disorder\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:sensory-processing-disorder":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,44,75,101,130,195],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100641244","ayres-sensory-integration-test-evaluation-results-and-neurodevelopmentally-focused-counseling-in-children-with-neurodevelopmental-problems-100641244",false,"NCT07656961","Ayres Sensory Integration Test Evaluation Results and Neurodevelopmentally Focused Counseling in Children With Neurodevelopmental Problems","Inclusion Criteria:\n\n* Aged 3-12\n* Sensory sensitivity (excessive or under-reaction to tactile, movement, auditory, or visual stimuli)\n* Have been referred by a pediatrician for neurodevelopmental monitoring\n* Have coordination difficulties\n* Difficulty organizing gross and\u002For fine motor movements\n* Activity level significantly above or below the norm for their age\n* Delays in academic achievement\n* Difficulties with daily living skills such as dressing and personal hygiene\n\nExclusion Criteria:\n\n* Being under 3 years of age or over 12 years of age\n* Having no conditions that fall outside normal developmental parameters",true,"ALL","3 Years","12 Years",{"count":20,"type":21},16,"ESTIMATED","1 Month","OBSERVATIONAL","The aim of the study is to investigate the long-term effects of ASI-based and hybrid neurodevelopmental counseling services on the variables of the Ayres Sensory Integration Assessment Test in children with neurodevelopmental disorders.",[26,27],"Sensory Processing Disorder","Neurodevelomental Disorders",[29,30,31],"Neurodevelopmental Disorders","Sensory Integration","EASI","NOT_YET_RECRUITING","2026-06-15",{"date":35,"type":36},"2026-06-18","ACTUAL",{"date":35,"type":21},{"date":39,"type":21},"2027-01-16",{"name":41,"class":42},"Yeditepe University","OTHER",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":16,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":55,"phases":56,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":43},"100637866","ayres-sensory-motor-integration-exercises-and-sensory-modulation-and-motor-skills-in-children-with-asd-100637866","NCT07576907","Ayre's Sensory-Motor Integration Exercises and Sensory Modulation And Motor Skills In Children With ASD","Effects of Ayre's Sensory-Motor Integration Exercises On Sensory Modulation And Motor Skills In Children With Autism Spectrum Disorder","Inclusion Criteria:\n\n* Diagnosis of Autism Spectrum Disorder (ASD) confirmed by a psychiatrist\u002Fpsychologist.\n* Children aged 9-11 years.\n* Moderate severity of ASD.\n\nExclusion Criteria:\n\n* Use of any sedative\u002Fhypnotic drugs.\n* Comorbid psychological or neurological disorders (e.g., epilepsy).\n* Withdrawal of consent at any point during the study.","9 Years","11 Years",{"count":54,"type":21},28,"INTERVENTIONAL",[57],"NA","This study will adopt a quasi-experimental design, featuring assessments before and after the intervention for both the experimental and control groups. We plan to recruit thirty children aged 9 to 11 years, all diagnosed with ASD, from a local clinical setting. Participants will be randomly assigned to either a treatment group, which will undergo 12 sessions of sensory-motor integration exercises, or a control group that will receive standard care. Each session will include structured sensory-based activities based on Ayres Sensory Integration® principles.",[60,26],"Motor Skills Disorders",[62,30,63,64],"Autism Spectrum Disorder","Motor Skills","Sensory Processing Disorders","RECRUITING","2026-05-04",{"date":68,"type":36},"2026-05-08",{"date":70,"type":36},"2026-04-01",{"date":72,"type":21},"2026-07-01",{"name":74,"class":42},"Riphah International University",{"id":76,"slug":77,"hasResults":11,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":81,"eligibilityCriteria":82,"healthyVolunteers":11,"sex":16,"minAge":83,"maxAge":18,"enrollmentInfo":84,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":86,"conditions":87,"keywords":88,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":94,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":43},"100612649","chiropractic-for-kids-with-sensory-processing-challenges-100612649","NCT07256327","Chiropractic for Kids With Sensory Processing Challenges","The Effects of Chiropractic on Kids With Sensory Processing Challenges: a Pilot Observational Study","SPD","Inclusion Criteria:\n\n* 5-12 years of age.\n* SSP total scores ≤154\n\nExclusion Criteria:\n\n* A known heart condition, including pacemakers\n* Chiropractic care within the past 30 days","5 Years",{"count":85,"type":21},20,"The main aim of this pilot observational study is to investigate the feasibility of implementing our novel assessment battery in tandem with normal and customary chiropractic care in a practice-based setting using a pediatric population with parent-reported sensory processing disorder (SPD). The secondary aim is to assess potential changes in objective and subjective outcomes.",[26],[89,90,91,92,93,29],"Pediatrics","Chiropractic","Autonomic Nervous System","Pilot Projects","Sensation Disorders",{"date":68,"type":36},{"date":96,"type":21},"2026-08",{"date":98,"type":21},"2026-12",{"name":100,"class":42},"Life University",{"id":102,"slug":103,"hasResults":11,"nctId":104,"briefTitle":105,"officialTitle":105,"acronym":106,"eligibilityCriteria":107,"healthyVolunteers":15,"sex":16,"minAge":108,"maxAge":109,"enrollmentInfo":110,"targetDuration":4,"studyType":55,"phases":112,"briefSummary":113,"conditions":114,"keywords":116,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":120,"lastUpdatePostDateStruct":121,"startDateStruct":123,"completionDateStruct":125,"leadSponsor":127,"locationsCount":129},"100543864","sensory-and-cognitive-predictions-and-their-disruptions-in-schizophrenia-100543864","NCT06361407","Sensory and Cognitive Predictions, and Their Disruptions in Schizophrenia","SensoSchiz","Inclusion Criteria:\n\n* Male or female;\n* Age between 18 and 60 inclusive;\n* Subject having dated and signed the consent form prior to the start of any trial-related procedure (guardian or curator where applicable);\n* Member of a social security scheme or beneficiary of such a scheme.\n\nExclusion Criteria:\n\n* Psychoactive substance use disorders (as defined by the DSM-V) (Diagnostic and Statistical Manual-V);\n* Use of benzodiazepines, hallucinogens (in the period preceding before inclusion, for a duration equivalent to 5 half-lives of the product) or cannabis (in the 2 months preceding inclusion);\n* Neurological pathology or sequelae;\n* Attention deficit hyperactivity disorder (ADHD);\n* Borderline personality disorder;\n* Disabling sensory disorders (visual acuity \\\u003C0.8);\n* Person deprived of liberty or under court protection;\n* Pregnant, parturient or breast-feeding women;\n* Subjects in a period of exclusion defined by another clinical study.","18 Years","60 Years",{"count":111,"type":21},68,[57],"Disturbances in the sense of self and time could play an important role in the development of psychotic symptoms. Previous work has shown that patients have difficulty preparing to process information on the scale of a second, but are abnormally disturbed by slightly asynchronous information on the millisecond scale. In both cases, the anomalies could explain the patients' unusual experience of time. The hypothesis in neurotypical patients is that small delays or asynchronies asynchronies are treated as irrelevant information and ignored and ignored, whereas in patients suffering from schizophrenia they would disrupt the flow of time. This hypothesis is tested with a new visual illusion.",[115,26],"Schizophrenia",[117,118,119],"sensory prediction","motion perception","prediction error","2026-03-24",{"date":122,"type":36},"2026-03-25",{"date":124,"type":36},"2024-06-28",{"date":126,"type":21},"2027-10-28",{"name":128,"class":42},"Centre Psychothérapique de Nancy",2,{"id":131,"slug":132,"hasResults":11,"nctId":133,"briefTitle":134,"officialTitle":135,"acronym":136,"eligibilityCriteria":137,"healthyVolunteers":11,"sex":16,"minAge":138,"maxAge":18,"enrollmentInfo":139,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":141,"conditions":142,"keywords":163,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":187,"lastUpdatePostDateStruct":188,"startDateStruct":189,"completionDateStruct":191,"leadSponsor":193,"locationsCount":43},"100630855","intensive-multimodal-neurorehabilitation-targeting-neuroplasticity-in-pediatric-neurodevelopmental-and-chromosomal-disorders-100630855","NCT07493096","Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders","Functional and Neurodevelopmental Outcomes Following Intensive Multimodal Neurorehabilitation in Pediatric Patients With Neurodevelopmental Disorders, Including Chromosomal Abnormalities","GEN-HOPE","Inclusion Criteria:\n\n* Pediatric participants between approximately 4 and 12 years of age at the time of enrollment.\n* Diagnosed with or presenting with neurodevelopmental, neurologic, or genetic conditions, including but not limited to:\n\n  * cerebral palsy\n  * autism spectrum disorder\n  * developmental delay\n  * hypoxic ischemic encephalopathy (HIE)\n  * traumatic brain injury\n  * sensory processing disorder\n  * chromosomal or genetic abnormalities\n  * Demonstrate functional impairments in one or more neurodevelopmental domains, including:\n* motor coordination or motor planning\n* sensory processing\n* attention or executive functioning\n* oculomotor or visual processing\n* communication\n* emotional or behavioral regulation\n* activities of daily living\n* Enrolled in and able to participate in a two-week intensive therapy program consisting of approximately 2.5 hours per day\u002F 5 days per week\n\n  * Able to complete baseline and post-program clinical assessment using clinician-observed or caregiver-reported measures.\n  * Parent or legal guardian able to provide informed consent and participate in reporting functional outcomes when applicable.\n\nExclusion Criteria:\n\n* Medical instability or acute medical condition that would prevent safe participation in an intensive therapy program.\n* Severe uncontrolled seizure activity or other neurologic condition that would interfere with participation in structured therapeutic activities, as determined by the treating clinician.\n* Behavioral or psychological conditions that would prevent safe engagement in the therapy environment despite appropriate support.\n* Inability to attend or complete the full two-week intensive program.\n* Lack of sufficient baseline or post-intervention data to assess change in functional performance.\n* Concurrent participation in another structured intervention or clinical study that would confound interpretation of functional outcomes, at the discretion of the investigator.","4 Years",{"count":140,"type":21},100,"This observational study evaluates functional and developmental outcomes in pediatric participants undergoing a two week intensive multimodal neurorehabilitation program. The program is designed for children with neurodevelopmental disorders, including but not limited to cerebral palsy, autism spectrum disorder, developmental delay, hypoxic ischemic encephalopathy (HIE), and chromosomal or genetic abnormalities.\n\nParticipants receive individualized therapy sessions for approximately 2.5 hours per day over a two week period. The intervention is not standardized but is tailored to each child's specific needs and may include components such as sensory integration, motor planning, reflex integration, oculomotor training, executive functioning activities, communication support, and other brain based therapeutic approaches.\n\nThe purpose of this study is to observe changes in functional abilities, including attention, motor coordination, emotional regulation, communication, and activities of daily living. Outcomes are assessed using clinician observation and parent reported changes before and after the intensive program, with limited follow-up when available.\n\nThis study does not assign participants to a specific treatment as part of a research protocol. Instead, it collects real world data from children already participating in a clinical therapy program to better understand potential benefits of intensive, individualized neurorehabilitation approaches.",[29,143,144,145,146,147,148,149,150,62,151,152,153,154,26,155,156,157,158,159,160,161,162],"Neurodevelopmental Disorders (NDD)","Neurodevelopmental Disorders and Developmental Abnormalities","Developmental Delay (Disorder)","Cerebral Palsy (CP)","Cerebral Palsy Hemiparetic Cerebral Palsy Spasticity Gait Disorders, Neurologic Postural Balance Impairment","Cerebral Palsy Infantile","Cerebral Palsy Spastic Hemiplegic","Cerebral Palsy, Dyskinetic","Autism Spectrum Disorder (ASD","Hypoxic Ischemic Encephalopathy","Hypoxic Ischemic Encephalopathy (HIE)","Traumatic Brain Injury (TBI)","Chromosomal Abnormalities","Genetic Disorders","Down Syndrome (Trisomy 21)","Fragile X Syndrome (FXS)","RETT Syndrome With Proven MECP2 Mutation","Williams Syndrome","22q11.2 Deletion Syndrome","Sensorimotor Integration",[164,165,166,167,168,169,170,171,172,173,30,174,175,176,177,178,179,180,29,181,182,183,184,185,186],"Photobiomodulation","Low-Level Laser Therapy","Vibration Therapy","Tactile Stimulation","Cognitive Training","Behavioral Therapy","Intensive Therapy","Pediatric Neurorehabilitation","Multimodal Therapy","Neuroplasticity","Reflex Integration","Motor Planning","Executive Function","Emotional Regulation","Functional Outcomes","Activities of Daily Living","High Frequency Therapy","Rehabilitation","Child Development Disorders","Occupational Therapy","Physical Therapy Modalities","Early Intervention","Cognitive Therapy","2026-03-19",{"date":122,"type":36},{"date":190,"type":36},"2026-03-01",{"date":192,"type":21},"2036-12-30",{"name":194,"class":42},"Healing Hope International",{"id":196,"slug":197,"hasResults":11,"nctId":198,"briefTitle":199,"officialTitle":200,"acronym":201,"eligibilityCriteria":202,"healthyVolunteers":11,"sex":16,"minAge":108,"maxAge":4,"enrollmentInfo":203,"targetDuration":4,"studyType":55,"phases":205,"briefSummary":206,"conditions":207,"keywords":210,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":216,"lastUpdatePostDateStruct":217,"startDateStruct":219,"completionDateStruct":221,"leadSponsor":223,"locationsCount":43},"100541043","who-and-why-do-patients-report-lymphedema-after-breast-cancer-treatment-without-an-objective-measurable-swelling-100541043","NCT06324721","Who and Why do Patients Report Lymphedema After Breast Cancer Treatment Without an Objective Measurable Swelling","The Enigma of Subjective Lymphedema: Who and Why do Patients Report Lymphedema After Breast Cancer Treatment Without an Objective Measurable Swelling? The Role of Lymphatic and Sensory Processing Problems","LymphSens","Inclusion criteria:\n\n1. adults (men and women) who are ≥ 18 years of age\n2. diagnosed with primary unilateral non-metastatic or oligometastatic breast cancer\n3. scheduled for surgery (mastectomy or breast conserving surgery; in combination with axillary lymph node dissection or sentinel node biopsy)\n4. able to read, understand, and speak Dutch\n5. have voluntary written informed consent of the patient\n\nExclusion Criteria:\n\n1. distant metastases\n2. planned bilateral lymph node surgery\n3. oedema of the arm from another cause\n4. an allergy to iodine or Indocyanine Green (ICG), or\n5. physically or mentally unable to participate throughout the entire duration of the study",{"count":204,"type":21},230,[57],"Breast cancer related lymphedema (BCRL) at the arm and\u002For trunk is an extremely dreaded complication after breast cancer treatment due to its chronicity and impact.\n\nThe incidence of objective arm and trunk\u002F breast BCRL is declining due to the major shift into the treatment approach of breast cancer. However, many patients report a sensation of swelling without the presence of objective BCRL, referred to as subjective BCRL. Therefore, subjective BCRL is defined as the diagnosis of BCRL based on the patient's sensation of a difference in size at the arm and\u002For trunk without the presence of objective BCRL.\n\nAt this moment, there is no clear information on the prevalence and the transitions between different BCRL states (no-subjective-objective) over time, as well as about the underlying mechanisms and contributing factors of subjective BCRL. Therefore, the investigators hypothesize that four mechanisms might be associated with the presence and severity of subjective arm or trunk\u002Fbreast BCRL, including the presence and\u002F or severity of lymphatic (1) and sensory processing problems (nociceptive (2), neuropathic (3), and\u002For central sensory processing problems (4)).\n\nThe investigators will set up a prospective longitudinal study with breast cancer patients to determine the prevalence of subjective and objective arm or trunk\u002F breast BCRL at 1, 6, and 12 month(s) post-surgery and the transitions between different BCRL states (no-subjective-objective BCRL) (AIM 1). In addition, factors related to four potential underlying mechanisms (lymphatic, nociceptive, neuropathic, and central sensory processing problems) that contribute to the occurrence of subjective BCRL in comparison to no self-reported swelling and objective BCRL will be determined (AIM 2). Furthermore, the present study will be undertaken to determine factors related to these four underlying mechanisms that contribute to the severity of subjective BCRL at arm or trunk\u002F breast BCRL within the group of patients with subjective BCRL at different time-points after surgery (at 1, 6, and 12 month(s) post-surgery) (AIM 3).",[208,209,26],"Breast Cancer","Lymphedema",[211,212,213,214,215],"lymphedema","subclinical edema","nociceptive problems","neuropathic problems","central sensory problems","2025-01-26",{"date":218,"type":36},"2025-01-29",{"date":220,"type":36},"2024-03-26",{"date":222,"type":21},"2027-05",{"name":224,"class":42},"Universitaire Ziekenhuizen KU Leuven"]